The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make ...

Novartis (SWX:NOVN) has seen its stock move steadily over the past month, reflecting a mix of investor sentiment and ongoing ...

Novartis has opened a 10,000ft² radioligand therapy (RLT) manufacturing facility in Carlsbad in the US state of California, ...

A well-tolerated antisense oligonucleotide yielded significant reductions in severe hypertriglyceridemia while lowering risk for acute pancreatitis in two phase 3 trials.

Novartis invests $23B in U.S. infrastructure, opening a new Carlsbad facility and expanding radioligand therapy sites. Read ...

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet ...

Novartis opens new radioligand therapy manufacturing facility in California as part of $23 billion US expansion plan: Basel Wednesday, November 12, 2025, 10:00 Hrs [IST] Novartis, ...

Swiss pharma giant Novartis announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing ...

Basel: Novartis, a global medicines company, has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) ...

Novartis, a global innovative medicines company, has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, CA.

The Pharmerging Market refers to the rapidly expanding pharmaceutical sectors in emerging economies, fueled by rising healthcare needs and the growing burden of chronic diseases. This market is ...